Paper16610047
Chemotherapy as a component of multimodal therapy for gastric carcinoma.
Kodera Y and 3 others. World J Gastroenterol, 2006. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Chemotherapy as a component of multimodal therapy for gastric carcinoma. Papers, record 16610047. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16610047
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stomach Neoplasms | Major topic |
| Chemotherapy, Adjuvant | |
| Combined Modality Therapy | |
| Humans |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12672044 | Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry. | Int J Cancer | 2003 | https://conductscience.org/library/papers/12672044 | PubMed |
| 2 | 15289487 | Chemotherapy sensitivity and resistance assays: a systematic review. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/15289487 | PubMed |
| 3 | 8620402 | A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. | Cancer | 1995 | https://conductscience.org/library/papers/8620402 | PubMed |
| 4 | 15718321 | Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15718321 | PubMed |
| 5 | 9404711 | The National Cancer Data Base report on gastric carcinoma. | Cancer | 1997 | https://conductscience.org/library/papers/9404711 | PubMed |
| 6 | 9591011 | Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. | Surgery | 1998 | https://conductscience.org/library/papers/9591011 | PubMed |
| 7 | 10089184 | Extended lymph-node dissection for gastric cancer. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10089184 | PubMed |
| 8 | 15521189 | Molecular method to quantitatively detect micrometastases and its clinical significance in gastrointestinal malignancies. | Adv Clin Chem | 2004 | https://conductscience.org/library/papers/15521189 | PubMed |
| 9 | 8658219 | Surgery for gastric cancer: the American view. | Semin Oncol | 1996 | https://conductscience.org/library/papers/8658219 | PubMed |
| 10 | 10077040 | Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. | Ann Surg | 1999 | https://conductscience.org/library/papers/10077040 | PubMed |
| 11 | 9552056 | Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. | J Clin Oncol | 1998 | https://conductscience.org/library/papers/9552056 | PubMed |
| 12 | 10917557 | Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10917557 | PubMed |
| 13 | 14532985 | Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer. | Int J Oncol | 2003 | https://conductscience.org/library/papers/14532985 | PubMed |
| 14 | 10705010 | Paclitaxel and concurrent radiation for gastric cancer. | Int J Radiat Oncol Biol Phys | 2000 | https://conductscience.org/library/papers/10705010 | PubMed |
| 15 | 9915239 | Total gastrectomy with extended lymphadenectomy for "curable" stomach cancer: experience in a non-Japanese Asian center. | J Am Coll Surg | 1999 | https://conductscience.org/library/papers/9915239 | PubMed |
| 16 | 10997811 | Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). | Ann Oncol | 2000 | https://conductscience.org/library/papers/10997811 | PubMed |
| 17 | 14662433 | Excisional surgery for cancer cure: therapy at a cost. | Lancet Oncol | 2003 | https://conductscience.org/library/papers/14662433 | PubMed |
| 18 | 11923135 | Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. | Ann Surg Oncol | 2002 | https://conductscience.org/library/papers/11923135 | PubMed |
| 19 | 10577853 | Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10577853 | PubMed |
| 20 | 868069 | Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. | World J Surg | 1977 | https://conductscience.org/library/papers/868069 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31696031 | 7-H-Pyrrolo[2,3-d]pyrimidine derivative acts as promising agent for gastric cancer treatment by inducing cell death. | 3 Biotech | 2019 | https://conductscience.org/library/papers/31696031 | PubMed |
| 31545303 | Inhibition of Proliferation of SGC7901 and BGC823 Human Gastric Cancer Cells by Ursolic Acid Occurs Through a Caspase-Dependent Apoptotic Pathway. | Med Sci Monit | 2019 | https://conductscience.org/library/papers/31545303 | PubMed |
| 30569134 | Corilagin induces apoptosis, autophagy and ROS generation in gastric cancer cells in vitro. | Int J Mol Med | 2019 | https://conductscience.org/library/papers/30569134 | PubMed |
| 23673986 | Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts. | Med Oncol | 2013 | https://conductscience.org/library/papers/23673986 | PubMed |
| 22674056 | Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. | Cancer Immunol Immunother | 2012 | https://conductscience.org/library/papers/22674056 | PubMed |
| 21792349 | Long-term survival of resected advanced gastric cancer with hepatic and pancreatic invasion. | Case Rep Gastroenterol | 2011 | https://conductscience.org/library/papers/21792349 | PubMed |
| 21160641 | Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma. | World J Gastrointest Oncol | 2010 | https://conductscience.org/library/papers/21160641 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16610047
GET https://conductscience.org/api/papers/v1/16610047/references?page=2